Total for the last 12 months
number of access : ?
number of downloads : ?
ID 118011
Author
Imakura, Takeshi Tokushima University
Murakami, Kojin Tokushima University
Takahashi, Naoki Tokushima University
Mima, Masato Tokushima University
Kagawa, Kozo Tokushima University
Nishimura, Haruka Tokushima University
Nokihara, Hiroshi Tokushima University
Keywords
lenvatinib
interstitial pneumonia
hepatocellular carcinoma
Content Type
Journal Article
Description
Lenvatinib is a multi-targeted tyrosine kinase inhibitor available for the treatment of unresectable hepatocellular carcinoma (HCC). We herein report an 84-year-old-man with interstitial pneumonia caused by lenvatinib. Four months after the start of lenvatinib administration for HCC, chest computed tomography revealed bilateral ground-glass opacity. However, he continued to take lenvatinib for four more months until he complained of dyspnea on exertion. This is a case of lenvatinib-induced interstitial pneumonia that progressed relatively slowly with a long asymptomatic period despite the appearance of pneumonia on image findings.
Journal Title
Internal Medicine
ISSN
13497235
Publisher
The Japanese Society of Internal Medicine
Volume
61
Issue
8
Start Page
1211
End Page
1217
Published Date
2022-04-15
Rights
The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
EDB ID
DOI (Published Version)
URL ( Publisher's Version )
FullText File
language
eng
TextVersion
Publisher
departments
University Hospital
Medical Sciences